JP2007515433A - Cyp26aおよびcyp26bの選択的阻害剤を使用するレチノイド反応性障害の処置方法 - Google Patents
Cyp26aおよびcyp26bの選択的阻害剤を使用するレチノイド反応性障害の処置方法 Download PDFInfo
- Publication number
- JP2007515433A JP2007515433A JP2006545811A JP2006545811A JP2007515433A JP 2007515433 A JP2007515433 A JP 2007515433A JP 2006545811 A JP2006545811 A JP 2006545811A JP 2006545811 A JP2006545811 A JP 2006545811A JP 2007515433 A JP2007515433 A JP 2007515433A
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- mmol
- disorder
- selective
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53060103P | 2003-12-17 | 2003-12-17 | |
| PCT/US2004/041889 WO2005058301A1 (en) | 2003-12-17 | 2004-12-13 | Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007515433A true JP2007515433A (ja) | 2007-06-14 |
| JP2007515433A5 JP2007515433A5 (cg-RX-API-DMAC7.html) | 2008-02-07 |
Family
ID=34700149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006545811A Pending JP2007515433A (ja) | 2003-12-17 | 2004-12-13 | Cyp26aおよびcyp26bの選択的阻害剤を使用するレチノイド反応性障害の処置方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7468391B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1696899A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007515433A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2550010A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005058301A1 (cg-RX-API-DMAC7.html) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009041482A1 (ja) * | 2007-09-28 | 2009-04-02 | Fujifilm Corporation | アセチレン化合物 |
| JP2010532355A (ja) * | 2007-06-29 | 2010-10-07 | アキュセラ インコーポレイテッド | 眼の疾患及び障害を治療するアルキニルフェニル誘導体化合物 |
| WO2020171146A1 (ja) * | 2019-02-20 | 2020-08-27 | 第一三共株式会社 | アゾール誘導体 |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017395B2 (en) | 2004-12-17 | 2011-09-13 | Lifescan, Inc. | Seeding cells on porous supports |
| AU2006202209B2 (en) * | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
| JP2009500297A (ja) * | 2005-06-08 | 2009-01-08 | セントカー・インコーポレーテツド | 眼の変性についての細胞療法 |
| US8741643B2 (en) * | 2006-04-28 | 2014-06-03 | Lifescan, Inc. | Differentiation of pluripotent stem cells to definitive endoderm lineage |
| KR101057546B1 (ko) * | 2007-06-05 | 2011-08-17 | 주식회사 엘지화학 | 광학 이방성 화합물 및 이를 포함하는 수지 조성물 |
| US9080145B2 (en) * | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
| RU2473685C2 (ru) | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
| CN107574142B (zh) | 2007-11-27 | 2021-07-06 | 生命扫描有限公司 | 人胚胎干细胞的分化 |
| BRPI0908033A2 (pt) | 2008-02-21 | 2015-08-04 | Centocor Ortho Biotech Inc | Método placas de superfície modificada e composições para adesão, cultura e desprendimento de célula |
| US8623648B2 (en) | 2008-04-24 | 2014-01-07 | Janssen Biotech, Inc. | Treatment of pluripotent cells |
| CA2729121C (en) | 2008-06-30 | 2019-04-09 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
| CN108486040A (zh) * | 2008-06-30 | 2018-09-04 | 詹森生物科技公司 | 多能干细胞的分化 |
| US20100028307A1 (en) * | 2008-07-31 | 2010-02-04 | O'neil John J | Pluripotent stem cell differentiation |
| EP2346988B1 (en) * | 2008-10-31 | 2017-05-31 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells to the pancreatic endocrine lineage |
| JP2012507289A (ja) | 2008-10-31 | 2012-03-29 | ヤンセン バイオテツク,インコーポレーテツド | ヒト胚性幹細胞の膵内分泌系への分化 |
| CA2744227C (en) * | 2008-11-20 | 2018-10-02 | Centocor Ortho Biotech Inc. | Methods and compositions for cell attachment and cultivation on planar substrates |
| MX2011005288A (es) | 2008-11-20 | 2011-06-01 | Centocor Ortho Biotech Inc | Celulas madre pluripotentes en microportadores. |
| EP2456858B1 (en) * | 2009-07-20 | 2018-08-29 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| EP2456862A4 (en) | 2009-07-20 | 2013-02-27 | Janssen Biotech Inc | DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS |
| RU2540016C2 (ru) | 2009-07-20 | 2015-01-27 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека |
| US20120190716A1 (en) * | 2009-08-05 | 2012-07-26 | Oehlen Lambertus J W M | Methods and uses of cytochrome p450 inhibitors |
| RU2664864C1 (ru) | 2009-12-23 | 2018-08-23 | Янссен Байотек, Инк. | Способы увеличения экспрессии ngn3 и nkx6.1 в эндокринных клетках поджелудочной железы |
| DK2516625T3 (da) | 2009-12-23 | 2024-09-09 | Janssen Biotech Inc | Differentiering af humane embryonale stamceller |
| AU2011223900A1 (en) * | 2010-03-01 | 2012-09-13 | Janssen Biotech, Inc. | Methods for purifying cells derived from pluripotent stem cells |
| AU2011250912A1 (en) | 2010-05-12 | 2012-11-22 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
| WO2012030540A2 (en) | 2010-08-31 | 2012-03-08 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells |
| CN103221536B (zh) | 2010-08-31 | 2016-08-31 | 詹森生物科技公司 | 人胚胎干细胞的分化 |
| KR101836850B1 (ko) | 2010-08-31 | 2018-03-09 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
| US9248120B2 (en) | 2011-08-23 | 2016-02-02 | The Board Of Trustees Of The Leland Stanford Junior University | Reversing intestinal inflammation by inhibiting retinoic acid metabolism |
| JP2014527083A (ja) | 2011-09-15 | 2014-10-09 | アリゾナ ボード オブ リージェンツ, ア ボディー コーポレイト オブ ザ ステート オブ アリゾナ, アクティング フォー アンド オン ビハーフ オブ アリゾナ ステート ユニバーシティー | 治療用化合物 |
| RU2705001C2 (ru) | 2011-12-22 | 2019-11-01 | Янссен Байотек, Инк. | Дифференцировка эмбриональных стволовых клеток человека в одногормональные инсулинположительные клетки |
| MX354775B (es) | 2012-03-07 | 2018-03-20 | Janssen Biotech Inc | Medios definidos para la expansion y el mantenimiento de celulas madre pluripotentes. |
| CN104334719B (zh) | 2012-06-08 | 2018-02-13 | 詹森生物科技公司 | 人胚胎干细胞向胰腺内分泌细胞的分化 |
| KR102084561B1 (ko) | 2012-12-31 | 2020-03-04 | 얀센 바이오테크 인코포레이티드 | 췌장 내분비 세포로의 분화를 위한 공기-액체 계면에서의 인간 배아 줄기세포의 배양 |
| DK2938722T3 (da) | 2012-12-31 | 2022-02-14 | Janssen Biotech Inc | Suspension og klyngedannelse af humane pluripotente celler til differentiering til endokrine pankreasceller |
| MX2015008578A (es) | 2012-12-31 | 2015-09-07 | Janssen Biotech Inc | Diferenciacion de celulas madre embrionarias humanas en celulas endocrinas pancreaticas mediante el uso de relugadores de hb9. |
| US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
| WO2015109318A2 (en) | 2014-01-17 | 2015-07-23 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Therapeutic methods |
| SG11201609473XA (en) | 2014-05-16 | 2016-12-29 | Janssen Biotech Inc | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
| WO2016055800A2 (en) * | 2014-10-10 | 2016-04-14 | High Force Research Limited | Fluorescent synthetic retinoids |
| CN105481723B (zh) * | 2015-04-29 | 2017-08-25 | 中国农业大学 | 一种非均相催化的烷基/苄基/芳基脲类化合物的制备方法 |
| WO2017091762A1 (en) | 2015-11-25 | 2017-06-01 | Io Therapeutics, Inc. | Use of cyp26-resistant rar alpha selective agonists in the treatment of cancer |
| CN107176945B (zh) * | 2016-03-11 | 2021-06-08 | 中国科学院上海有机化学研究所 | 一种视黄酸类化合物、其制备方法、中间体及应用 |
| WO2017180361A1 (en) | 2016-04-14 | 2017-10-19 | Janssen Biotech, Inc. | Differentiation of pluripotent stem cells to intestinal midgut endoderm cells |
| US10231947B2 (en) | 2017-01-23 | 2019-03-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Isochroman compounds and methods of use thereof |
| US10238626B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Therapeutic compounds |
| US10238655B2 (en) | 2017-01-23 | 2019-03-26 | Arizona Board Of Regents On Behalf Of Arizona State University | Dihydroindene and tetrahydronaphthalene compounds |
| WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
| WO2019057946A1 (en) | 2017-09-25 | 2019-03-28 | F. Hoffmann-La Roche Ag | MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS |
| WO2019113693A1 (en) * | 2017-12-12 | 2019-06-20 | Queen's University At Kingston | Compounds and methods for inhibiting cyp26 enzymes |
| WO2019121143A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Substituted cyclopropyl derivatives |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001044443A2 (en) * | 1999-12-16 | 2001-06-21 | Cytochroma Inc. | Cytochrome p450rai-2 and related proteins |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5599967A (en) | 1994-12-29 | 1997-02-04 | Allergan | Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity |
| US5952345A (en) | 1995-09-01 | 1999-09-14 | Allergan Sales, Inc. | Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| US5723666A (en) | 1996-06-21 | 1998-03-03 | Allergan | Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| WO2002048334A2 (en) | 2000-12-15 | 2002-06-20 | Cytochroma Inc. | P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereof |
| US6303785B1 (en) | 2000-08-29 | 2001-10-16 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6252090B1 (en) * | 2000-08-29 | 2001-06-26 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6313107B1 (en) | 2000-08-29 | 2001-11-06 | Allergan Sales, Inc. | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| US6380256B1 (en) * | 2000-08-29 | 2002-04-30 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US6387951B1 (en) * | 2000-08-29 | 2002-05-14 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
| US20030166932A1 (en) | 2002-01-04 | 2003-09-04 | Beard Richard L. | Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| GB0204735D0 (en) * | 2002-02-28 | 2002-04-17 | Inpharmatica Ltd | Protein |
| CN1819996B (zh) | 2003-07-10 | 2010-10-27 | Osi制药公司 | 作为细胞色素p450抑制剂的亚萘基衍生物 |
| US7226951B2 (en) * | 2003-12-17 | 2007-06-05 | Allergan, Inc. | Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
-
2004
- 2004-12-13 JP JP2006545811A patent/JP2007515433A/ja active Pending
- 2004-12-13 US US11/010,953 patent/US7468391B2/en not_active Expired - Fee Related
- 2004-12-13 EP EP04814113A patent/EP1696899A1/en not_active Withdrawn
- 2004-12-13 WO PCT/US2004/041889 patent/WO2005058301A1/en not_active Ceased
- 2004-12-13 CA CA002550010A patent/CA2550010A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001044443A2 (en) * | 1999-12-16 | 2001-06-21 | Cytochroma Inc. | Cytochrome p450rai-2 and related proteins |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010532355A (ja) * | 2007-06-29 | 2010-10-07 | アキュセラ インコーポレイテッド | 眼の疾患及び障害を治療するアルキニルフェニル誘導体化合物 |
| US8299307B2 (en) | 2007-06-29 | 2012-10-30 | Acucela Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| US8389771B2 (en) | 2007-06-29 | 2013-03-05 | Acucela, Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| US8492589B2 (en) | 2007-06-29 | 2013-07-23 | Acucela Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| US8766007B2 (en) | 2007-06-29 | 2014-07-01 | Acucela Inc | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| US8895782B2 (en) | 2007-06-29 | 2014-11-25 | Acucela Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| US9115056B2 (en) | 2007-06-29 | 2015-08-25 | Acucela Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| US9464033B2 (en) | 2007-06-29 | 2016-10-11 | Acucela Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
| WO2009041482A1 (ja) * | 2007-09-28 | 2009-04-02 | Fujifilm Corporation | アセチレン化合物 |
| WO2020171146A1 (ja) * | 2019-02-20 | 2020-08-27 | 第一三共株式会社 | アゾール誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| US7468391B2 (en) | 2008-12-23 |
| WO2005058301A1 (en) | 2005-06-30 |
| CA2550010A1 (en) | 2005-06-30 |
| EP1696899A1 (en) | 2006-09-06 |
| US20050187298A1 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7468391B2 (en) | Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B | |
| JP2007514773A (ja) | 選択的シトクロムp450rai−1または選択的シトクロムp450rai−2阻害活性を有する化合物およびそれを得る方法 | |
| US6387892B1 (en) | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI | |
| JP2001504458A (ja) | レチノイド受容体に対し作動剤、拮抗剤または逆作動剤型活性を有するn―アリール置換テトラヒドロキノリンリガンド | |
| JP2003509399A (ja) | 製薬学的性質を有する新規なジカルボン酸誘導体 | |
| US6291677B1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| JP2001515516A (ja) | 血管損傷剤としてのコルヒノール誘導体の使用 | |
| DE60116642T2 (de) | Verbindungen mit cytochrom p450ra1 hemmenden aktivität | |
| AU2001286471A1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| US6359135B1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| US6303785B1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| AU2003213848B2 (en) | Substituted chroman derivatives having cytochrome P450RAI inhibitory activity | |
| US7019034B2 (en) | Compositions and methods for reducing serum glucose and triglyceride levels in diabetic mammals | |
| US6387951B1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| US6369261B1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| US6380256B1 (en) | Compounds having activity as inhibitors of cytochrome P450RAI | |
| MXPA06006820A (en) | Methods for treating retinoid responsive disorders using selective inhibitors of cyp26a and cyp26b | |
| US6734193B1 (en) | (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity | |
| US6884820B2 (en) | 5,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activity | |
| TW201930261A (zh) | 光學活性之反式蝦紅素衍生物或其鹽、及含有該等化合物之組合物 | |
| SG172277A1 (en) | Cyclohexanecarboxamide derivatives useful as inhibitors of cholesteryl ester transfer protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20071212 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071212 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110104 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110706 |